Live Breaking News & Updates on தாமஸ் எ.கா.

Stay updated with breaking news from தாமஸ் எ.கா.. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Investegate |BB BIOTECH AG Announcements | BB BIOTECH AG: Vaccines leading the way out of the pandemic


DGAP-News: BB BIOTECH AG
/ Key word(s): Annual Results/Dividend
BB BIOTECH AG: Vaccines leading the way out of the pandemic - increased dividend of CHF 3.60 proposed
22.01.2021 / 07:00
Media release as of January 22, 2021
Portfolio of BB Biotech AG as of December 31, 2020
Vaccines leading the way out of the pandemic - increased dividend of CHF 3.60 proposed
BB Biotech performed well in 2020 in a volatile market environment. The biotech sector made significant strides, leading the effort against the SARS-CoV-2 virus pandemic through approved mRNA vaccines and therapeutic antibodies. M&A activity picked up substantially in H2 2020, further driving solid performance as the year came to a close. The fourth quarter alone drove a portfolio gain of 20.6% in CHF, 20.4% in EUR and 25.5% in USD for BB Biotech - reflecting a net gain of CHF 665 mn. In parallel, the share price appreciated by 10.9% in CHF and 9.0% in EUR. BB Biotech exited four holdings and added ....

United States , White House , District Of Columbia , Neurocrine Biosciences , Jeffreyd Zients , Tanja Chicherio , Claude Mikkelsen , Bristol Myers Squibb , Silvia Siegfried Schanz , Xavier Becerra , Thomas Egger , Maria Grazia Iten Alderuccio , Investment Management Team Of Bellevue Asset , Scholar Rock Holding , Alnylam Pharmaceuticals , Generation Bio Co , Kezar Life Sciences , Radius Health , Dow Jones , Obama National Economic Council , Vertex Pharmaceuticals , Alexion Pharmaceuticals , Ute Communications , Nektar Therapeutics , Agios Pharmaceuticals , Myovant Sciences ,